Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Compared with the TG treatment group, activation of GLP-1R by liraglutide markedly decreased the number of apoptotic cells
Key Takeaways The most common side effects are digestive issues like nausea, diarrhoea, vomiting, and constipation, similar to other GLP-1 medications Some participants experienced mild increases in heart rate at higher doses, but this decreased over time Side effects are typically worse when starting treatment or increasing doses, then improve as your body adjusts Long-term side effects are unknown as trials have only lasted up to one year so far Retatrutide is still in clinical trials and not available for prescription yet By entering I agree to the Terms and Conditions
10.1002/iub.572 IUBMB Life 39 HalliwellB.CheahI
The system is broken and needs to be fixed.
Coverage was current as of April 2023
The phase 2 and phase 3 clinical trials use a systemic stepwise titration to gradually increase the retatrutide dose to help the body adjust and reach the therapeutically effective dose with minimal side effects
US$ 23.06
US$ 20.55
US$ 20.26
US$ 21.37
US$ 24.59
US$ 21.59
US$ 23.03
